Followers | 129 |
Posts | 2150 |
Boards Moderated | 1 |
Alias Born | 12/27/2007 |
Thursday, April 02, 2015 12:09:19 PM
http://telestatherapeutics.com/cms/phpjDm0WL.pdf
Investment Opportunity
•New management team has led transformative change
•Focused on unencumbered, late stage, near-commercial asset for bladder cancer
•BLA filing targeted in Q2/2015 with potential US approval in Q1/2016
•Significant dialogue with US FDA to minimize regulatory risk
•Independent assessment of U.S. market opportunity, market access and pricing
•MCNA specialty product profile validated by 3rd party expressions of interest
•Multiple opportunities to create shareholder value through the achievement of significant regulatory milestones, potential partnering or company sale before or after the US FDA’s BLA decision
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM